N.H. Admin. Code § Ph 1506.01

Current through Register No. 49, December 5, 2024

Section Ph 1506.01 - Review of Program Data

(a) The program vendor shall collect and monitor all prescription drug monitoring information required by RSA 318-B:33, IV, and Ph 1504.01(b).

(b) The program vendor shall review and evaluate the collected information in order to identify behavior that suggests possible drug abuse, misuse, or diversion, or possible violations of law or breaches of professional standards.

(c) The program vendor shall consider, at a minimum, the following patient-related factors in its evaluation in (b) above:

(1) Number of in-state prescribers;

(2) Number of out-of-state prescribers;

(3) Number of prescriptions;

(4) Number of doses;

(5) Overlapping prescriptions;

(6) Unhealthy combinations of controlled substances;

(7) Method of payment;

(8) Number and frequency of pharmacies used; and

(9) Dangerous levels of controlled substances.

(d) The program vendor shall consider, at a minimum, the following prescriber/dispenser-related factors in its evaluation in (b) above:

(1) Number of prescriptions;

(2) Number of doses;

(3) Overlapping prescriptions;

(4) Unhealthy combinations of controlled substances;

(5) Number and frequency of pharmacies used;

(6) Dangerous levels of controlled substances;

(7) Electronic program access and use; and

(8) For dispensers only, method of payment.

N.H. Admin. Code § Ph 1506.01

#10526, eff 2-26-14

Amended by Volume XXXVIII Number 06, Filed February 8, 2018, Proposed by #12465, Effective 1/23/2018, Expires 1/23/2028.